These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2905898)

  • 21. The medical therapy of peptic ulcer.
    Bevan G
    Postgrad Med J; 1975; 51(5 Suppl):14-8. PubMed ID: 7780
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term management of peptic ulcer disease.
    Lewis JH
    Compr Ther; 1989 Feb; 15(2):55-61. PubMed ID: 2647388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and radiographical study on the effects of the treatment of peptic ulcer with a new antacid-antiulcer agent].
    Piro E; Florio F; Tripodi R
    Clin Ter; 1970 May; 53(4):323-48. PubMed ID: 4394193
    [No Abstract]   [Full Text] [Related]  

  • 27. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Financial cost of the treatment of peptic ulcer].
    Castro Lde P; de Souza ZP; Ribeiro Tde C; Coelho LG; Avelar CD
    AMB Rev Assoc Med Bras; 1986; 32(1-2):21-4. PubMed ID: 2878471
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors].
    Tsukamoto Y; Niwa Y; Arisawa T
    Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
    Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of ulcer with a new antacid-antisecretive-antispastic combination].
    Castellazzi V; Marenco G; Ghibaudi D
    Clin Ter; 1969 Apr; 49(1):47-61. PubMed ID: 4396961
    [No Abstract]   [Full Text] [Related]  

  • 34. Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists.
    Jones AW
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):5-12. PubMed ID: 27119574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptic ulcers in the elderly: unique features and management.
    Freston MS; Freston JW
    Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of peptic ulcer disease in the arthritic patient.
    Nunes D; Kennedy NP; Weir DG
    Drugs; 1989 Sep; 38(3):451-61. PubMed ID: 2680437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New views on the physiopathology of peptic ulcer].
    Ottenjann R
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):181-4. PubMed ID: 4149847
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effect of a new antisecretory and anti-acid drug].
    Galli L; Bissi A
    Rev Bras Gastroenterol; 1967; 19(3):43-9. PubMed ID: 4387428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.